Articles: 25.21 5 November 2014

Chronic hepatitis B: diagnosis, monitoring and management

Hepatitis B is a blood-borne DNA virus and chronic disease is defined as failure to clear the virus within six months of initial infection. Here, the authors discuss at-risk groups and outline diagnosis, monitoring and treatment.
Chronic hepatitis B diagnosis monitoring and management

More details...

Latest reviews from Cochrane

In this section we present an abstract of a review relevant to prescribing in general practice from the latest issue of The Cochrane Database of Systematic Reviews. To view the article in full or for further information, visit www.thecochranelibrary.com
Clobazam monotherapy for partial onset or generalized …

More details...

Drug points: second-generation antipsychotics

Steve Chaplin and Dr Mark Taylor provide an overview of the properties of second-generation antipsychotics in the management of psychotic illnesses
Drug points second generation antipsychotics

More details...

Improving adherence needs a multipronged approach

There is no universal formula to help patients with medicines adherence but there are a number of interventions that can help. Rachel Elliott explores some of the options outlined in the existing data.
Improving adherence needs a multipronged approach

More details...

Osteoarthritis: recent advances in diagnosis and management

Osteoarthritis represents a failure of joint tissue repair and can be diagnosed accurately by symptoms and clinical findings. Our Drug review discusses diagnosis and management, including holistic assessment and pharmacological and nonpharmacological treatment, followed by sources of further information and an analysis of the prescription …

More details...

Polypharmacy – what is it and how common is it?

In the first of a series of articles the authors of a King’s Fund report on polypharmacy outline the scale of the issue and how medicines optimisation could be used to mitigate against the problem.
Polypharmacy what is it and how common is it

More details...

Preventing drug-induced acute kidney injury in the community

Acute kidney injury (AKI) is a common and increasing problem globally. AKI affects one in six patients admitted to hospital as an emergency, costing the NHS in England £434–620 million a year, and the profile of AKI has recently been raised by the launch of …

More details...

Simvastatin improves outcome of venous ulcers

In this small study, simvastatin provided clinically significant improvements in time-to-healing and total healing rates, especially for venous ulcers smaller than 5cm in diameter.
Simvastatin improves outcome of venous ulcers

More details...

Treclin: tretinoin/clindamycin combination for acne

Treclin, a once-daily topical formulation of tretinoin and clindamycin, is licensed for the treatment of acne. In our New products review, Steve Chaplin presents the clinical data relating to it efficacy and adverse events.
Treclin tretinoin clindamycin combination for acne

More details...

Why does asthma still kill?

With effective medication and evidence-based management guidance why should anyone die from asthma? Steve Chaplin examines the reasons and looks at how it can be avoided.
Why does asthma still kill

More details...

Web design and marketing agency Leamington Spa